✦ LIBER ✦
Phase I/II Trial of the Addition of Erlotinib to Pre- and Postoperative Chemotherapy/Hyperfractionated Radiotherapy, and as Maintenance, for Resectable Mediastinoscopy-defined Stage III Non–small-cell Lung Cancer (NSCLC): Report on the Phase II Component
✍ Scribed by G.M. Videtic; T. Rice; S. Murthy; D. Mason; P. Mazzone; N. Pennell; M. Shapiro; C. Reddy; J. Samsa; T. Mekhail
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 42 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.